The presence of biofilm within drain environments poses a significant threat to patient safety. An analysis of studies relating to drain biofilm was carried out* and it has been determined that sink drainage systems are a reservoir for hospital-acquired colonisation or infection.
BioClenz+ is specifically designed for use in hospital and healthcare facilities targeting biofilm within drains and nearby wet surfaces, and the microbes harbouring within them.
BioClenz+ is a unique solid dose formulation and is tested against the only registered protocol that demonstrates kill efficacy against Staphylococcus aureus and Pseudomonas aeruginosa in biofilms. BioClenz+ also has a residual efficacy claim, which means for the treatment of wet areas the product continues to provide protection for a further 24 hours.
The presence of biofilm within drain environments poses a significant threat to patient safety. An analysis of studies relating to drain biofilm was carried out* and it has been determined that sink drainage systems are a reservoir for hospital-acquired colonisation or infection.
BioClenz+ is specifically designed for use in hospital and healthcare facilities targeting biofilm within drains and nearby wet surfaces, and the microbes harbouring within them.
BioClenz+ is a unique solid dose formulation and is tested against the only registered protocol that demonstrates kill efficacy against Staphylococcus aureus and Pseudomonas aeruginosa in biofilms. BioClenz+ also has a residual efficacy claim, which means for the treatment of wet areas the product continues to provide protection for a further 24 hours.
* Almatroud 2016, Staphylococcus aureus, dry surface biofilms are not killed by sodium hypochlorite: implications for infection control, Journal of Hopital infections.
Bioclenz+ is also registered and authorised in Ireland, in accordance with the Biocide Product Regulation (BPR).